NCT05800574 - Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 14, 2023

Primary Completion Date

September 23, 2025

Study Completion Date

September 23, 2027

Conditions

Oropharynx Cancer

Interventions

RADIATION

Radiation therapy (5 days for 7 weeks)

Mon-Fri (5 days for 7 weeks), total 35 fractions over 35 treatment days of radiation therapy (RT)

RADIATION

Radiation therapy (5 days for 6 weeks)

Mon-Fri (5 days for 6 weeks), total 35 fractions over 30 treatment days of RT (two doses 6 hours apart except for the last 6th Friday of the 6 weeks )

DRUG

Cisplatin

Cisplatin, 40mg/m2 (weekly for 7 weeks)

Trial Locations (1)

19111

RECRUITING

Fox Chase Cancer Center, Philadelphia